Montag & Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12
Closed -$489 982
2026
Q1
$489 Sell
12
-7
-37% -$331 ﹤0.01% 925
2025
Q4
$851 Sell
19
-1
-5% -$46 ﹤0.01% 931
2025
Q3
$906 Sell
20
-7
-26% -$335 ﹤0.01% 1030
2025
Q2
$1.3K Hold
27
﹤0.01% 898
2025
Q1
$1.08K Buy
27
+3
+13% +$126 ﹤0.01% 943
2024
Q4
$1.11K Hold
24
﹤0.01% 941
2024
Q3
$1.14K Hold
24
﹤0.01% 965
2024
Q2
$1.03K Sell
24
-2
-8% -$88 ﹤0.01% 932
2024
Q1
$1.16K Buy
+26
New +$1.19K ﹤0.01% 912

Other funds holding QGEN

Montag & Associates's QGEN Position: Q2 2026 in Review

Montag & Associates sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 12 shares — an estimated $489 sold.

Montag & Associates first reported a position in QGEN in Q1 2024 and held it in 9 quarters. The position peaked at $1.3K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Montag & Associates reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Montag & Associates sold 12 Qiagen shares in Q2 2026, an estimated $489.
  • Montag & Associates first reported a position in Qiagen in Q1 2024 and held it in 9 quarters.
  • Montag & Associates's Qiagen position peaked at $1.3K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.